OMX30 1 514 -0,6%  OMXH25 3 676 -0,3%  OMXC20 900 0,2%  Dow 19 886 0,0%  Nas 5 060 0,4%  EUR 9,4926 0,1%  USD 8,9564 0,2%  Olja 55,4 -0,3%  Guld 1 204 0,5% 

Edwards Lifesciences Aktie

97,12USD -0,46USD -0,47%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Edwards Lifesciences

2015 2016e 2017e 2018e 2019e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal 34,69 33,96 28,66 25,11 22,30
Resultat/aktie 2,29 2,86 3,39 3,87 4,36

Nyheter om Edwards Lifesciences Corp.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Edwards Lifesciences Corp.

ytterligare analyser

Edwards Lifesciences Peer Group

Edwards Lifesciences 97,12
-0,5%
pagehit

Lägg till instrument

Vad tycker du?

Profil Edwards Lifesciences Corp.

till bolagsprofilen
Edwards Lifesciences Corp. is focused on technologies that treat structural heart disease and critically ill patients. It designs, develops, manufactures and markets products to treat stage cardiovascular disease. Its products and technologies are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Critical Care portfolio products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems. The portfolio also includes a line of balloon catheter-based vascular products, surgical clips and inserts. Edwards Lifesciences was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Realtidskurs Edwards Lifesciences Corp.

Bid
97,08
USD
Ask
97,10
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Edwards Lifesciences Corp. i USDPUSH CHART

Kurs 97,12 USD -0,46 -0,47 %
Kurstid 21:59:53
Datum 13.01.2017
Öppning 97,66
Gårdagen 97,12
Dagshögsta 97,71
Dagslägsta 96,17
52 v. högsta 121,74
52 v. lägsta 72,20
52 v. perf.
Volym (Antal) 134 561
Börsvärde (SEK) 184,87 Mrd
Börsen
Kurs för 97,12 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 869,85 SEK.

Till aktien Edwards Lifesciences

Ticker
ISIN US28176E1082
Index S&P 500

Edwards Lifesciences Nyckeltal

Börsvärde i SEK 184,87 Mrd
Free float % 99,19
Antal aktier mio. 213,81
Cashflow/aktie i lokal valuta 2,58
Bokvärde/aktie i lokal valuta 11,44
60 dagar vola 54,11
PBV 6,94

Edwards Lifesciences Historiska kurser

2017-01-13 97,12 134 561
2017-01-12 97,58 87 845
2017-01-11 98,64 83 690
2017-01-10 99,10 104 529
2017-01-09 97,98 100 726